| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/01/2000 | EP0982400A1 Human glycine transporter |
| 03/01/2000 | EP0982027A1 Taxoid derivatives for treating abnormal cell proliferation of the brain |
| 03/01/2000 | EP0981620A1 Hgf polypeptides and their use in therapy |
| 03/01/2000 | EP0981550A1 Methods for eosinophil depletion and compositions therefor |
| 03/01/2000 | EP0981547A1 Tumor-associated antigen |
| 03/01/2000 | EP0981377A1 Immobilized activity stabilized lhrh antagonist complexes, method for the production thereof |
| 03/01/2000 | EP0981372A2 Compositions of antichlamydial agents for the diagnosis and management of infection caused by chlamydia |
| 03/01/2000 | EP0981362A1 Methods of enhancing functioning of the upper gastrointestinal tract |
| 03/01/2000 | EP0981361A1 Method of treating sepsis |
| 03/01/2000 | EP0981360A1 Method for preventing gastritis using amylin or amylin agonists |
| 03/01/2000 | EP0981352A1 Aplidine as an l-type calcium channel enhancer |
| 03/01/2000 | EP0981338A1 ORAL PREPARATION FOR THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF $i(HELICOBACTER SP.) INFECTION |
| 03/01/2000 | EP0981330A1 Topical compositions |
| 03/01/2000 | EP0861070B1 Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis |
| 03/01/2000 | EP0821592A4 Compositions and methods for regulating hair growth |
| 03/01/2000 | EP0594739B1 Cancer treatment |
| 03/01/2000 | CN1049891C Dicyclomine compound and preparing method, and drug composition containing said compound |
| 03/01/2000 | CA2246791A1 Treatment of endothelium with somatostatin analogues |
| 02/29/2000 | US6031090 Molecular cloning of a 7TM receptor (GPR31A) |
| 02/29/2000 | US6031080 Chemotactic cytokine |
| 02/29/2000 | US6031077 For prevention and treatment of heartworm infections; parasiticides; anthelmintics |
| 02/29/2000 | US6031007 A homogenous dental emulsion or microemulsion of local anesthetic in oil form, a surfactant having thermoreversible gelling properties, i.e. thickening when contacting mucous membranes, and water; pathological periodontal pockets; scale |
| 02/29/2000 | US6031004 Metformin (2:1) fumarate and metformin (2:1) succinate; antidiabetic and hypoglycemic agents; improved handling, i.e. lower hygroscopicity, free-flowing, reduced compaction susceptibiity, corrosion resistance; improved taste |
| 02/29/2000 | US6030953 For preventing and treating anal leakage of oil in a patient |
| 02/29/2000 | US6030948 Hair regeneration compositions for treatment of alopecia and methods of application related thereto |
| 02/29/2000 | US6030943 Dehydrodidemnin B as an L-type calcium channel enhancer |
| 02/29/2000 | US6030825 Cyclophilin-type peptidyl-prolyl cis/trans isomerase |
| 02/29/2000 | US6030811 Polynucleotides encoding a human mystrophin clone, HSABH01 |
| 02/29/2000 | US6030801 Amino acid sequence of enzyme; for screening a library for molecules which bind the polypeptide; diagnosis, treatment or prevention of cancer, immune and reproductive disorders; anticarcinogenic agents |
| 02/29/2000 | US6030785 Incubating a mixture containing pkr protein kinase, a viral protein containing an interferon sensitivity determining region, and an agent to be tested; then measuring the protein kinase activity where activity indicates an antiviral agent |
| 02/29/2000 | US6030783 Photo-potentiation of cisplatin chemotherapy |
| 02/29/2000 | US6030617 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
| 02/29/2000 | US6030613 Receptor specific transepithelial transport of therapeutics |
| 02/29/2000 | US6030604 Formulation for inhalation |
| 02/29/2000 | CA2280049A1 Diarylsulfonylurea binding proteins |
| 02/28/2000 | CA2249037A1 Novel compounds |
| 02/24/2000 | WO2000009709A2 Proteases and associated proteins |
| 02/24/2000 | WO2000009695A2 Drug targets in candida albicans |
| 02/24/2000 | WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | WO2000009662A1 Transgenic nonhuman mammal and uses thereof to identify compounds useful for improving long-term memory |
| 02/24/2000 | WO2000009653A2 Method of inhibiting cathepsin k |
| 02/24/2000 | WO2000009558A1 Hepatitis c inhibitor peptides |
| 02/24/2000 | WO2000009552A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | WO2000009550A1 Vanadate resistance glycosylation 4 gene |
| 02/24/2000 | WO2000009549A2 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 02/24/2000 | WO2000009541A1 nrdE |
| 02/24/2000 | WO2000009537A2 Compounds having growth hormone releasing activity |
| 02/24/2000 | WO2000009507A1 Phenyl yanthine derivatives |
| 02/24/2000 | WO2000009503A1 Integrin receptor antagonists |
| 02/24/2000 | WO2000009489A1 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists |
| 02/24/2000 | WO2000009176A1 A wound treatment composition and a wound dressing containing it |
| 02/24/2000 | WO2000009162A1 Preventives/remedies for glaucoma |
| 02/24/2000 | WO2000009131A1 Diaminopyrimidines and combination therapies effective for treatment of p-glycoprotein positive cancers |
| 02/24/2000 | WO2000009130A2 New pharmaceutical uses for nos inhibitors |
| 02/24/2000 | WO2000009124A1 Pyrrolidine derivatives for vision and memory disorders |
| 02/24/2000 | WO2000009123A1 Pharmaceutical compositions containing lipase inhibitors and chitosan |
| 02/24/2000 | WO2000009122A1 Pharmaceutical compositions containing lipase inhibitors |
| 02/24/2000 | WO2000009120A1 New use of taxoid derivatives |
| 02/24/2000 | WO2000009113A1 Use of zeranol to modulate reproductive cycles |
| 02/24/2000 | WO2000009110A2 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | WO2000009109A2 Pipecolic acid derivatives for vision and memory disorders |
| 02/24/2000 | WO2000009108A2 Compositions and uses for vision and memory disorders |
| 02/24/2000 | WO2000009107A2 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | WO2000009102A2 Carboxylic acids and isosteres of n-heterocyclic compounds for vision and memory disorders |
| 02/24/2000 | WO2000009099A2 Treatment of vasodilatory headache |
| 02/24/2000 | WO2000009087A1 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 02/24/2000 | WO2000009085A2 Oral formulation containing cyclosporin |
| 02/24/2000 | WO2000009073A2 Blood-brain barrier therapeutics |
| 02/24/2000 | WO2000009070A2 Inhibition of pathogenic processes related to tissue trauma |
| 02/24/2000 | WO2000002579A3 Component b as angiogenic agent in combination with human growth factors |
| 02/24/2000 | WO1999064050A8 Novel potassium channel drugs and their uses |
| 02/24/2000 | WO1999062459A3 Agents and methods for protection, treatment and repair of connective tissue |
| 02/24/2000 | WO1999058692A3 Human apoptosis associated proteins |
| 02/24/2000 | WO1999049774A9 Methods for the diagnosis and treatment of lung cancer |
| 02/24/2000 | WO1999045127A3 Enhanced prodrug activation |
| 02/24/2000 | DE19837790A1 Manufacture of human pharmaceuticals, foodstuffs and cosmetics comprises the use of one or more physiologically compatible gases to enrich and potentiate the activity of the basic ingredients |
| 02/24/2000 | DE19837758A1 Verwendung von Wirkstoffkombinationen aus Flavonoiden und UV-Filtersubstanzen als antivirales Wirkprinzip Use of active compound combinations of flavonoids and UV filters as an antiviral action principle |
| 02/24/2000 | CA2344520A1 Pipecolic acid derivatives for vision and memory disorders |
| 02/24/2000 | CA2340702A1 Pyrrolidine derivatives for vision and memory disorders |
| 02/24/2000 | CA2340419A1 Carboxylic acids and isosteres of n-heterocyclic compounds for vision and memory disorders |
| 02/24/2000 | CA2340418A1 Blood-brain barrier therapeutics |
| 02/24/2000 | CA2340350A1 Phenyl yanthine derivatives |
| 02/24/2000 | CA2340200A1 New pharmaceutical uses for nos inhibitors |
| 02/24/2000 | CA2340176A1 Inhibition of pathogenic processes related to tissue trauma |
| 02/24/2000 | CA2340167A1 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists |
| 02/24/2000 | CA2340117A1 Treatment of vasodilatory headache |
| 02/24/2000 | CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | CA2339338A1 Vanadate resistance glycosylation 4 gene |
| 02/24/2000 | CA2339337A1 Drug targets in candida albicans |
| 02/24/2000 | CA2339328A1 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 02/24/2000 | CA2339047A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | CA2338878A1 Integrin receptor antagonists |
| 02/24/2000 | CA2338386A1 Proteases and associated proteins |
| 02/24/2000 | CA2336148A1 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | CA2336080A1 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | CA2335815A1 Compositions and uses for vision and memory disorders |
| 02/24/2000 | CA2301201A1 Method of inhibiting cathepsin k |
| 02/23/2000 | EP0980684A2 Use of active substance combinations comprising flavonoids and uv filters as antiviral active principle |
| 02/23/2000 | EP0980386A2 Estrogen receptor crystals and ligands |
| 02/23/2000 | EP0980385A1 Peptides and compounds that bind to the il-5 receptor |